
Mobile Medical Application for Cost-Effective Strabismus ScreeningAward last edited on: 12/19/2017
Sponsored Program
SBIRAwarding Agency
NIH : NEITotal Award Amount
$1,164,798Award Phase
2Solicitation Topic Code
-----Principal Investigator
Matteo TomasiCompany Information
Phase I
Contract Number: 1R43EY025902-01Start Date: 9/1/2015 Completed: 8/31/2016
Phase I year
2015Phase I Amount
$152,948Public Health Relevance Statement:
Public Health Relevance:
Strabismus (crossed eyes) affects an estimated 3-8% of the U.S. population and is a leading risk factor for vision degradation in children due to amblyopia. In the elderly and in head trauma victims, strabismus can lead to postural instability and is associated with increased risk of potentially incapacitating injuries. Early diagnosis and treatment are key to mitigating these risk factors and preventing serious vision loss or injury, bu public health efforts to screen for strabismus have been hampered by significant barriers of cost and the need for highly trained examiners. A recent study reported that only 40% of children in the U.S. receive vision screening by age 6. The overall goal of the proposed Phase I project is to develop an automated, cost-effective, smart phone-based strabismus screening application that can be used by lay people as well as clinicians, thereby enabling strabismus screening to become widely available to under- served, at-risk populations.
NIH Spending Category:
Behavioral and Social Science; Bioengineering; Brain Disorders; Clinical Research; Comparative Effectiveness Research; Congenital Structural Anomalies; Eye Disease and Disorders of Vision; Health Services; Neurosciences; Pediatric; Prevention; Rural Health
Project Terms:
3 year old; Affect; Age; Amblyopia; Area; Awareness; base; Biomedical Engineering; Blindness; Brain Injuries; Caliber; Caring; Cellular Phone; Child; Childhood; Clinical; clinical decision-making; Clinical Investigator; Clinical Trials; Collaborations; college; Color; commercialization; Cornea; cost; cost effective; Costs and Benefits; Craniocerebral Trauma; Detection; Development; Devices; Early Diagnosis; Early treatment; Elderly; Environment; Equilibrium; Esotropia; Evaluation; Exhibits; Eye; fall risk; falls; gang; Glosso-Sterandryl; Goals; Head; Health Resources; Health Services Accessibility; Hospitals; Image; improved; Individual; Injury; Institution; Iris (Eye); Lead; lens; Light; Low income; Marketing; Measurement; Measures; Medical; meetings; Methodology; Methods; Neighborhoods; New England; novel; Ophthalmology; Optometry; patient population; Patients; Performance; performance tests; Persons; Phase; Population; Populations at Risk; portability; Posture; Prevalence; prevent; Prevention; programs; prototype; public health medicine (field); public health relevance; Pupil; Rehabilitation therapy; Relative (related person); Reporting; Reproducibility; research clinical testing; Research Institute; Research Personnel; Risk; Risk Factors; Rural; rural area; sample fixation; screening; Sensitivity and Specificity; Shapes; software development; Software Engineering; Specialist; Strabismus; stroke; Structure; System; Target Populations; Testing; tool; Training; Trauma patient; tv watching; Vision; Vision Screening; Visual impairment
Phase II
Contract Number: 2R44EY025902-02Start Date: 00/00/00 Completed: 00/00/00
Phase II year
2017(last award dollars: 2018)
Phase II Amount
$1,011,850Public Health Relevance Statement:
PROJECT NARRATIVE Strabismus (crossed eyes) affects an estimated 3-8% of the U.S. population and is a leading risk factor for vision degradation in children due to amblyopia. In the elderly and in head trauma victims, strabismus can lead to postural instability and is associated with increased risk of potentially incapacitating injuries. Early diagnosis and treatment are key to mitigating these risk factors and preventing serious vision loss or injury, but public health efforts to screen for strabismus have been hampered by significant barriers of cost and the need for highly trained examiners. A recent study reported that only 40% of children in the U.S. receive vision screening by age 6. The overall goal of the proposed Phase II project is to complete development and clinic-based performance evaluation of an automated, cost-effective, smartphone-based strabismus screening application (EyeTurn) that can be used by lay people as well as clinicians, thereby enabling strabismus screening and measurement to become widely available to under-served, at-risk populations.
Project Terms:
Address; Adopted; Adult; Affect; Age; Algorithms; Amblyopia; Area; base; Blindness; Boston; Caring; Cellular Phone; Child; Childhood; Clinic; Clinical; clinical Diagnosis; Clinical Trials; Color; commercialization; Computer software; Cornea; cost; cost effective; Costs and Benefits; Craniocerebral Trauma; Data; data management; design; Detection; Development; Devices; Doctor of Optometry; Early Diagnosis; Early treatment; Elderly; Esotropia; Evaluation; Eye; falls; Financial compensation; gaze; Goals; Health Insurance Portability and Accountability Act; Health Services Accessibility; Home environment; Hospitals; Image; improved; Incidence; Individual; Injury; invention; Iris; Lead; Legal patent; Light; Long-Term Care for Elderly; Low income; Measurement; Measures; Medical; Methodology; Methods; Motor; novel; Ophthalmologist; Ophthalmology; Optometrist; Patient Education; patient population; Patients; Performance; Persons; Phase; Population; Populations at Risk; Positioning Attribute; posture instability; Preparation; Prevalence; prevent; Prevention; Privatization; product development; programs; Public Health; Pupil; Rehabilitation therapy; Reporting; Research; research clinical testing; Research Institute; response; Risk; Risk Factors; Rural; Scientist; screening; Sensitivity and Specificity; Shapes; software development; Specificity; Strabismus; Structure; Study Subject; success; Suggestion; Target Populations; Technology; Telemedicine; Testing; tool; Training; usability; Use Effectiveness; Vision; Vision Screening; Visual impairment